Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Finished Goods (2019 - 2025)

Pulmonx (LUNG) has disclosed Finished Goods for 7 consecutive years, with $13.9 million as the latest value for Q3 2025.

  • Quarterly Finished Goods fell 10.31% to $13.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13.9 million through Sep 2025, down 10.31% year-over-year, with the annual reading at $14.7 million for FY2024, 7.76% down from the prior year.
  • Finished Goods for Q3 2025 was $13.9 million at Pulmonx, up from $13.6 million in the prior quarter.
  • The five-year high for Finished Goods was $16.4 million in Q1 2023, with the low at $8.6 million in Q1 2021.
  • Average Finished Goods over 5 years is $14.2 million, with a median of $14.7 million recorded in 2024.
  • The sharpest move saw Finished Goods soared 90.18% in 2021, then fell 14.49% in 2025.
  • Over 5 years, Finished Goods stood at $12.0 million in 2021, then surged by 30.03% to $15.6 million in 2022, then increased by 2.12% to $16.0 million in 2023, then decreased by 7.76% to $14.7 million in 2024, then dropped by 5.73% to $13.9 million in 2025.
  • According to Business Quant data, Finished Goods over the past three periods came in at $13.9 million, $13.6 million, and $14.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.